Real-World Effectiveness of Tezepelumab for Patients with Severe Asthma in the United States: CROSSROADS-3
- DOI
- 10.1016/j.anai.2026.09.737
- Published
- 2026-09
- Container
- Annals of Allergy, Asthma & Immunology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.anai.2026.09.737,
title = {Real-World Effectiveness of Tezepelumab for Patients with Severe Asthma in the United States: CROSSROADS-3},
author = {Jessica K. DeMartino and Christopher S. Ambrose and Santiago Zuluaga Sanchez and Benjamin Emmanuel and Renee L. Gennarelli and Temitope Bello and Andrew Lindsley and Jean-Pierre Llanos and Laren Tan and Weily Soong},
year = {2026},
journal = {Annals of Allergy, Asthma \& Immunology},
doi = {10.1016/j.anai.2026.09.737},
url = {https://doi.org/10.1016/j.anai.2026.09.737}
}RIS
TY - JOUR TI - Real-World Effectiveness of Tezepelumab for Patients with Severe Asthma in the United States: CROSSROADS-3 AU - Jessica K. DeMartino AU - Christopher S. Ambrose AU - Santiago Zuluaga Sanchez AU - Benjamin Emmanuel AU - Renee L. Gennarelli AU - Temitope Bello AU - Andrew Lindsley AU - Jean-Pierre Llanos AU - Laren Tan AU - Weily Soong PY - 2026 JO - Annals of Allergy, Asthma & Immunology DO - 10.1016/j.anai.2026.09.737 UR - https://doi.org/10.1016/j.anai.2026.09.737 ER -
APA
DeMartino, J. K., Ambrose, C. S., Sanchez, S. Z., Emmanuel, B., Gennarelli, R. L., Bello, T., Lindsley, A., Llanos, J., Tan, L., & Soong, W. (2026). Real-World Effectiveness of Tezepelumab for Patients with Severe Asthma in the United States: CROSSROADS-3. Annals of Allergy, Asthma & Immunology. https://doi.org/10.1016/j.anai.2026.09.737
Source records
- crossref · retrieved 2026-09-25T12:13:24.130Z